FDA Drug Application (203533) for RISEDRONATE SODIUM by MACLEODS PHARMS LTD

Back to FDA Applications sponsored by MACLEODS PHARMS LTD

Application Number203533
Product Number001
FormTABLET;ORAL
Dosage5MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameRISEDRONATE SODIUM
Active IngredientRISEDRONATE SODIUM

Active IngredientCount
List of drugs with Active Ingredient RISEDRONATE SODIUM4


Back to FDA Applications sponsored by MACLEODS PHARMS LTD